237 related articles for article (PubMed ID: 30945308)
1. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma.
Zayed SA; Zahran NM; Khorshied MM; Abdel-Aziz AO; Mahmoud O; Morsy SA; Shousha HI; Elbaz TM; Nabeel MM; Harb ARK
J Med Virol; 2019 Aug; 91(8):1537-1544. PubMed ID: 30945308
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
Alsalawy NF; Darwish RK; Kamal MM; ElTaweel AE; Shousha HI; Elbaz TM
J Med Virol; 2018 Mar; 90(3):490-496. PubMed ID: 28975649
[TBL] [Abstract][Full Text] [Related]
3. TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients.
Körner C; Riesner K; Krämer B; Eisenhardt M; Glässner A; Wolter F; Berg T; Müller T; Sauerbruch T; Nattermann J; Spengler U; Nischalke HD
BMC Cancer; 2012 Mar; 12():85. PubMed ID: 22401174
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) do not contribute but Death Receptor (DR4) genes may contribute to susceptibility to head and neck cancer in Pakistani population.
Sarwar R; Mansoor Q; Farooqi AA; Shahzad S; Fayyaz S; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):53-6. PubMed ID: 26718429
[TBL] [Abstract][Full Text] [Related]
5. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
6. TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis.
Chen B; Liu S; Wang XL; Xu W; Li Y; Zhao WH; Wu JQ
Eur J Cancer; 2009 Sep; 45(14):2598-605. PubMed ID: 19643596
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.
Khorshied M; Soliman N; Khorshid O; Bakr S
Cancer Biomark; 2021; 32(4):451-458. PubMed ID: 34275891
[TBL] [Abstract][Full Text] [Related]
8. Association of four polymorphisms in the death receptor 4 gene with cancer risk: an updated meta-analysis.
Lu J; Qin Q; Zhan LL; Liu J; Zhu HC; Zhang C; Xu LP; Liu ZM; Yang X; Cheng HY; Sun XC
Tumour Biol; 2014 Jun; 35(6):5149-58. PubMed ID: 24492941
[TBL] [Abstract][Full Text] [Related]
9. Association of DR4 (TRAIL-R1) polymorphisms with cancer risk in Caucasians: an updated meta-analysis.
Chen W; Tang WR; Zhang M; Chang K; Wei YL
Asian Pac J Cancer Prev; 2014; 15(6):2889-92. PubMed ID: 24761920
[TBL] [Abstract][Full Text] [Related]
10. Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population.
Rai R; Sharma KL; Sharma S; Misra S; Kumar A; Mittal B
PLoS One; 2014; 9(2):e90264. PubMed ID: 24587306
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in DNA-repair genes (XRCC1, 3, and 7) and the susceptibility to hepatocellular carcinoma in a cohort of Egyptians.
Aboul Enein AA; Khaled IAA; Khorshied MM; Abdel-Aziz AO; Zahran N; El Saeed AM; Shousha HI; Abdel Rahman HA
J Med Virol; 2020 Dec; 92(12):3609-3616. PubMed ID: 32281666
[TBL] [Abstract][Full Text] [Related]
12. There is no significant association between death receptor 4 (DR4) gene polymorphisms and lung cancer in Turkish population.
Taştemir-Korkmaz D; Demirhan O; Kuleci S; Hastürk S
Pathol Oncol Res; 2013 Oct; 19(4):779-84. PubMed ID: 23661154
[TBL] [Abstract][Full Text] [Related]
13. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
ELBassuoni MA; Abd El Fatah G; Zaghla H
Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
16. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
17. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population.
Zahoor A; Mansoor Q; Farooqi AA; Fayyaz S; Naz G; Ismail M
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):108-12. PubMed ID: 26518902
[TBL] [Abstract][Full Text] [Related]
19. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
20. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]